Skip to main content
. 2005 Sep 8;33(6):523–530. doi: 10.1165/rcmb.2004-0220RC

Figure 3.

Figure 3.

Dose-dependent effects of IL-13 on MUC5AC and hCLCA1 expression by primary human TBE cells in vitro. Well differentiated primary human TBE cells were prepared as described in the text, and treated with IL-13 at doses from 2 to 50 ng/ml for 24 h as shown. (A) Effects of IL-13 doses on MUC5AC expression by primary human TBE cells. (B) Effects of IL-13 doses on hCLCA1 expression by primary human TBE cells. n = 4; *P < 0.018; **P < 0.001; ***P < 0.007.